Menu
GeneBe

FREM2

FRAS1 related extracellular matrix 2

Basic information

Region (hg38): 13:38687076-38887131

Links

ENSG00000150893NCBI:341640OMIM:608945HGNC:25396Uniprot:Q5SZK8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Fraser syndrome 1 (Definitive), mode of inheritance: AR
  • Fraser syndrome 2 (Moderate), mode of inheritance: AR
  • Fraser syndrome (Supportive), mode of inheritance: AR
  • renal agenesis, unilateral (Supportive), mode of inheritance: AD
  • Fraser syndrome 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Fraser syndrome 2; Cryptophthalmos, unilateral or bilateral, isolatedARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal15838507; 18203166; 18000968; 18671281; 30802441

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FREM2 gene.

  • not provided (717 variants)
  • Fraser syndrome 2 (361 variants)
  • Inborn genetic diseases (159 variants)
  • Fraser syndrome 2;Isolated cryptophthalmia (59 variants)
  • not specified (53 variants)
  • Isolated cryptophthalmia;Fraser syndrome 2 (41 variants)
  • Fraser syndrome 1 (32 variants)
  • FREM2-related condition (14 variants)
  • Isolated cryptophthalmia (9 variants)
  • Microcephaly (2 variants)
  • Congenital anomaly of kidney and urinary tract (2 variants)
  • Childhood-onset schizophrenia (1 variants)
  • Congenital diaphragmatic hernia (1 variants)
  • Epidermolysis bullosa simplex with nail dystrophy (1 variants)
  • 8 conditions (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FREM2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
21
clinvar
232
clinvar
18
clinvar
271
missense
2
clinvar
410
clinvar
20
clinvar
23
clinvar
455
nonsense
10
clinvar
6
clinvar
3
clinvar
19
start loss
1
clinvar
1
frameshift
18
clinvar
9
clinvar
27
inframe indel
0
splice donor/acceptor (+/-2bp)
4
clinvar
1
clinvar
5
splice region
3
15
3
21
non coding
98
clinvar
47
clinvar
89
clinvar
234
Total 28 21 534 299 130

Highest pathogenic variant AF is 0.0000197

Variants in FREM2

This is a list of pathogenic ClinVar variants found in the FREM2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-38687085-A-G Fraser syndrome 2 Benign (Jun 21, 2021)311927
13-38687094-A-G Fraser syndrome 2 Uncertain significance (Jan 13, 2018)311928
13-38687101-G-T Fraser syndrome 2 Uncertain significance (Jan 12, 2018)311929
13-38687126-G-A Fraser syndrome 2 Uncertain significance (Jan 13, 2018)311930
13-38687152-T-C Fraser syndrome 2 Uncertain significance (Jan 12, 2018)311931
13-38687163-G-A Fraser syndrome 2 Likely benign (Jan 13, 2018)311932
13-38687312-A-G Fraser syndrome 2 Uncertain significance (Jan 13, 2018)884194
13-38687345-A-G Fraser syndrome 2 Uncertain significance (Jan 13, 2018)311933
13-38687356-C-A Likely benign (Oct 28, 2023)2868784
13-38687356-C-T Likely benign (Dec 07, 2023)2909248
13-38687356-CG-C Fraser syndrome 2 Pathogenic (Apr 10, 2019)625181
13-38687357-G-T Inborn genetic diseases Uncertain significance (Nov 13, 2023)3096786
13-38687358-G-T Inborn genetic diseases Uncertain significance (Nov 13, 2023)3096788
13-38687368-G-A Likely benign (Oct 07, 2023)2766654
13-38687374-C-T Likely benign (Dec 23, 2022)2823527
13-38687382-G-A Fraser syndrome 2 Uncertain significance (Apr 10, 2022)286386
13-38687382-G-T Uncertain significance (Dec 22, 2022)2571709
13-38687383-G-C Likely benign (May 19, 2023)2865685
13-38687386-A-G Likely benign (Oct 18, 2023)2802735
13-38687396-A-G Inborn genetic diseases Uncertain significance (Jun 06, 2022)2209069
13-38687409-C-T Fraser syndrome 2 • Fraser syndrome 2;Isolated cryptophthalmia Uncertain significance (Jul 02, 2022)884195
13-38687410-A-G Likely benign (Jun 16, 2023)2868625
13-38687425-G-A Likely benign (Sep 22, 2023)2997900
13-38687428-C-G not specified • Fraser syndrome 2 • Fraser syndrome 2;Isolated cryptophthalmia Benign/Likely benign (Jan 31, 2024)193533
13-38687428-C-T Likely benign (Aug 29, 2023)2789532

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FREM2protein_codingprotein_codingENST00000280481 24198809
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.60e-111.0012561601321257480.000525
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.85918351.73e+31.060.000095020721
Missense in Polyphen393459.660.854985544
Synonymous-1.487276781.070.00003766524
Loss of Function6.05381050.3630.000006031236

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008790.000879
Ashkenazi Jewish0.0002980.000298
East Asian0.0001090.000109
Finnish0.0001390.000139
European (Non-Finnish)0.0006890.000686
Middle Eastern0.0001090.000109
South Asian0.0005230.000523
Other0.0004920.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Extracellular matrix protein required for maintenance of the integrity of the skin epithelium and for maintenance of renal epithelia. May be required for epidermal adhesion. {ECO:0000269|PubMed:15838507}.;
Disease
DISEASE: Fraser syndrome 2 (FRASRS2) [MIM:617666]: A form of Fraser syndrome, an autosomal recessive disorder characterized by cryptophthalmos, cutaneous syndactyly, and urogenital abnormalities including renal agenesis or hypoplasia. Additional features include abnormalities of the larynx, ear malformations, and facial abnormalities. {ECO:0000269|PubMed:15838507}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.112

Intolerance Scores

loftool
0.708
rvis_EVS
-0.63
rvis_percentile_EVS
16.77

Haploinsufficiency Scores

pHI
0.413
hipred
Y
hipred_score
0.604
ghis
0.479

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.838

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Frem2
Phenotype
pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; respiratory system phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); craniofacial phenotype;

Zebrafish Information Network

Gene name
frem2b
Affected structure
blood island
Phenotype tag
abnormal
Phenotype quality
blistered

Gene ontology

Biological process
eye development;morphogenesis of an epithelium;cell communication;cell adhesion;heart development;embryonic digit morphogenesis;inner ear development
Cellular component
basement membrane;plasma membrane;integral component of membrane;extracellular exosome
Molecular function
metal ion binding